Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer
<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....
Sábháilte in:
Príomhchruthaitheoirí: | , , , , , |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Archives of Clinical Nephrology - Peertechz Publications,
2017-03-27.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
Connect to this object online.3rd Floor Main Library
Gairmuimhir: |
A1234.567 |
---|---|
Cóip 1 | Ar fáil |